# FDA Inspection 823365 - Vitalant - March 18, 2013

Source: https://www.keypedia.com/records/fda_inspections/vitalant/5a3dbf6f-9994-4b4f-b028-07aa3875a49b
Source feed: FDA_Inspections

> FDA Inspection 823365 for Vitalant on March 18, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 823365
- Company Name: Vitalant
- Inspection Date: 2013-03-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1225687 - 2023-12-13](https://www.keypedia.com/records/fda_inspections/vitalant/08f44822-cb91-4142-bebc-d18944f8762f)
- [FDA Inspection 1079185 - 2018-12-20](https://www.keypedia.com/records/fda_inspections/vitalant/4f37bdab-6587-44ce-b59c-023a53d8b343)
- [FDA Inspection 998276 - 2016-12-02](https://www.keypedia.com/records/fda_inspections/vitalant/d3fc86d3-2da0-4647-9224-60560952ceb7)
- [FDA Inspection 903259 - 2014-11-05](https://www.keypedia.com/records/fda_inspections/vitalant/72643838-76ec-4bfa-81da-8045c231a45c)
- [FDA Inspection 721545 - 2011-04-26](https://www.keypedia.com/records/fda_inspections/vitalant/d88f42ad-bf03-4136-a8c4-a18e5df88769)

Company: https://www.keypedia.com/companies/vitalant/9f8bee99-db5d-4a24-8d57-a41c2beeb48a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d